retatrutide type 2 diabetes trial results 2024 produces up to 30.3% weight loss in Phase 3 Phase III retatrutide study demonstrates

Go to 0.5mg first

Plan to titrate to Ozempic 2 mg within four to eight weeks if your starting dose doesnt provide adequate appetite control

The SURMOUNT-1 trial tested the ability of tirzepatide to produce weight loss in people with obesity who do not have diabetes

GLP-1 receptor agonists, such as exenatide, help protect the ovarian and endometrial environments from oxidative stress, fibrosis, and chronic inflammation

Vehicle residence time is the second lever and is largely pathway-independent: a formulation cleared by mucociliary action before absorption is complete underperforms regardless of how well ionization or enhancer selection is optimized

Before first use: All GLP-1 medications should be stored in the refrigerator at 36F to 46F (2C to 8C) until first use or until the manufacturer's expiration date